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Objective: To evaluate the patterns of chromosome abnormalities in embryos derived from intracytoplasmic
sperm injection (ICSI) in microsurgical epididymal sperm aspiration (MESA) or testicular sperm extraction
(TESE) in comparison to embryos that are derived from naturally ejaculated (EJAC) patients.
Materials and methods: Male partners with azoospermia who required MESA or TESE for ICSI were
studied for chromosomal abnormalities. The ICSI patients with EJAC sperm served as the control group.
Preimplantation genetic diagnosis (PGD) was performed by ﬂuorescence in situ hybridization (FISH).
Chromosome abnormalities were categorized as polyploidy, haploidy, aneuploidy, and complex abnor-
mality (which involves more than two chromosomes). Fertilization, embryo development, and patterns
of chromosome abnormalities were accessed and evaluated.
Results: There was no difference between the MESA, TESE, and EJAC patient groups in the rates of
fertilization and pregnancy and the percentages of euploid embryos. In all three groups, less than one-
half of the embryos for each group were normal (41 ± 31%, 48 ± 38%, and 48 ± 31% in MESA, TESA, and
EJAC, respectively). Complex chromosomal abnormality was signiﬁcantly more frequent in the MESA
group than in the EJAC group (48.3% vs. 26.5%, respectively; p < 0.001). Furthermore, the overall pattern
of chromosomal aneuploidy was similar among all three studied groups.
Conclusion: We suggest that MESA and TESE, followed by ICSI and PGD, appear to be acceptable ap-
proaches for treating men with severe spermatogenesis impairment.
Copyright © 2014, Taiwan Association of Obstetrics & Gynecology. Published by Elsevier Taiwan LLC. All
rights reserved.Introduction
The introduction of intracytoplasmic sperm injection (ICSI) has
provided hope for treating men with severe spermatogenesis
impairment [1]. With obstructive azoospermia, sperm can be
retrieved from the blocked epididymis or from the seminiferous
tubules of the testes [i.e., microsurgical epididymal sperm aspira-
tion (MESA) or testicular sperm extraction (TESE) procedures]
[2e5]. With nonobstructive azoospermia, TESE can retrieve sperm
for successful fertilization in less than 60% of patients [4,6].ndocrinology and Infertility,
effen School of Medicine at
90095, USA.
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bstetrics & Gynecology. PublishedGenerally speaking, the fertilization and pregnancy rates from ICSI,
even with severe spermatogenic defects, are comparable to the
rates of conventional in vitro fertilization [4,7].
In obstructive azoospermia, sperm are preferably retrieved from
the epididymis at the ﬁrst attempt because it is easier for surgeons
and patients. If this fails, TESE can be pursued as an alternative. The
overall fertilization, cleavage, and pregnancy rates are not signiﬁ-
cantly different between cycles that use TESE and MESA sperm
sources. In addition, these rates are not affected by whether the
obstruction is caused by congenital absence of the vas deferens or
failed vasoepididymostomy [4].
Under physiologic conditions, sperm may survive for several
weeks in the epididymis with less than 7 days of fertilization
capability [8,9]. This creates a heterogeneous sperm population in
the epididymis by age and spermatozoa maturity. Therefore, there
may be an increase in the possibility of an overmature sperm beingby Elsevier Taiwan LLC. All rights reserved.
Table 1
The demographic data of the three investigated groups.
Group MESA TESE EJAC
No. of cases 11 11 101
Maternal age (y) 33.8 ± 4.4* 36.5 ± 4.0 38.5 ± 4.3*
No. of retrieved oocytes 10.6 ± 6.3 12.0 ± 8.4 9.4 ± 5.7
No. of mature oocytes 8.6 ± 5.3 8.5 ± 5.6 7.4 ± 4.2
Fertilization rate (%) 75 ± 20 71 ± 27 73 ± 26
No. of embryos for PGD 58 54 460
Embryo cleavage rate (%) 87 ± 30 83 ± 24 87 ± 20
Rate of no biopsy (%) 13 ± 30 23 ± 31 9 ± 15
Rate of euploidy (%) 41 ± 31 48 ± 38 48 ± 31
Pregnancy rate, % (no./total no.) 36 (4/11) 18 (2/11) 20 (20/101)
EJAC ¼ ejaculation; MESA ¼ microsurgical epididymal sperm aspiration;
PGD ¼ preimplantation genetic diagnosis; TESE ¼ testicular sperm extraction.
Some data are presented as the mean ± standard deviation.
*p ¼ 0.004.
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spermia has shown that testicular sperm DNA appears to be
signiﬁcantly less damaged than epididymal sperm DNA [10]. These
ﬁndings may explain the higher fertilization rate but lower im-
plantation potential with epididymal sperm [11].
In nonobstructive azoospermia, sperm can only be retrieved
from testicles and often present with the most unfavorable pa-
rameters. A recent study has shown that only 22% of TESE-derived
embryos were normal, compared to 41.8% of embryos from ICSI
cycles with ejaculated sperm [12]. These abnormalities include a
doubled rate of mosaic chromosomes in embryos from TESE (53%)
versus ICSI (26.5%). These ﬁndings can be explained by the fact that
TESE-derived sperm from men with nonobstructive azoospermia
have a higher rate of compromised or immature centrosome
structures, which leads to mosaicism in the embryos [12].
Several studies report an increased incidence of chromosomal
anomaliesdparticularly anomalies involving sex chromosomesdin
ICSI cycle-derived children in comparison to the incidence in the
normal newborn population [7,13e16]. In addition, the possibilities
of chromosomal anomalies in infertile males who require ICSI
treatment using TESE or MESA include meiotic disruption during
spermatogenesis [16] and an increased frequency of aneuploidy in
sperm [11,17,18].
Previous studies have revealed the correlation between severe
male infertility and sperm chromosomal abnormalities. However,
the rates of abnormalities in the chromosomal complement of mild
oligozoospermia-derived embryos that require ICSI and sperm
from MESA and TESE remain unclear; this is important when
counseling patients at the time of embryo transfer in the ICSI
procedure. Therefore, the aim of this study was to evaluate the rate
and pattern of chromosomal abnormalities in MESA-derived and
TESE-derived embryos and to compare these rates and patterns to
those of ICSI-derived embryos using naturally ejaculated sperm.
Materials and methods
Patient selection
This study was approved by Institutional Review Board (IRB) of
UCLA (Los Angeles, California, USA) in accordance with the Helsinki
Declaration of 1975 on human experimentation. Patients with se-
vere male factor infertility that required ICSI and who also received
preimplantation genetic diagnosis (PGD) between January 2005
and April 2006 were enrolled in this study. The sources of sperm
included MESA, TESE, and natural ejaculation (EJAC). For obstruc-
tive azoospermia, MESA was initially attempted to obtain viable
sperm. If no motile sperm cells were detected in the epididymal
sample, TESE was then performed. For nonobstructive azoospermic
patients, spermwas obtained by TESE. If the ejaculates on the day of
egg retrieval had less than 15 M/mL of sperm and/or a motility of
less than 20%, ICSI was performed. Patients who had PGDs after
EJAC/ICSI were the controls. Patients who had undergone oocyte
donation were excluded from this study.
ICSI and FISH analysis
Patients undergoing long or short ovulation induction protocols
in the ICSI cycle were enrolled in the study. When the dominant
follicle size exceeded 18 mm in diameter, 10,000 IU of human
chorionic gonadotropin (Profasi; Serono Merck Inc., Norwell, MA)
was administered. Approximately 34e36 hours later, oocytes were
transvaginally retrieved and cultured at 37C in human tubal ﬂuid
that was supplemented with 5% human serum albumin in a 5% CO2
humidiﬁed gas atmosphere. After 4 hours of incubation, ICSI was
performed. The embryos were cultured for 3 days in G1.3 medium(Vitrolife Products, Englewood, CO), and then underwent blasto-
mere biopsy for PGD. All viable embryos with at least four cells
were subjected to PGD analyses. After the biopsy, the embryoswere
switched to G2.3 medium (Vitrolife Products, Englewood, CO) for
growth to the blastocyst stage. Only embryos that were classiﬁed by
PGD as chromosomally normal were transferred.
Aneuploidy screening was performed with FISH using probes
primarily for chromosomes 13, 18, 21, X, and Y (Vysis Corporation,
Downers Cove, MI). Chromosome abnormalities were categorized
as haploidy, polyploidy, aneuploidy, and complex abnormality.
These four terms were deﬁned by the presence of one set of the
tested chromosomes (i.e., haploidy); more than two sets of the
tested chromosomes (i.e., polyploidy); one or two chromosomes
with an abnormal number of copies (i.e., aneuploidy); and more
than two chromosomes with an abnormal number of copies (i.e.,
complex abnormality) [19].Statistical analysis
The proportion of abnormal embryos was computed for each
patient for each type of investigated abnormality. Pair-wise com-
parisons were performed using the WilcoxoneManneWhitney
test. The KruskaleWallis test was used to compare heterogeneous
percentages between the three studied groups. All statistical ana-
lyses were performed using the SPSS statistical package software
(SPSS, Inc., Chicago, IL, USA).Results
In total, 572 embryos that were derived from 112 ICSI cycles
with natural ejaculated sperm and MESA or TESE were analyzed by
FISH. There were 58 embryos in 11 cycles in the MESA group, 54
embryos in 11 cycles in the TESE group, and 460 embryos in 101
cycles in the EJAC group.
As Table 1 shows, there was no difference between these three
groups in the number of retrieved eggs, number of mature oocytes,
rates of fertilization, cleavage, and embryos that underwent a bi-
opsy for PGD. There was also no difference in the pregnancy rate.
Maternal age was the only variable that differed and was more
advanced in the EJAC group (38.5 ± 4.3 years), compared to the
maternal age in the MESA and TESE groups (33.8 ± 4.4 years and
36.5 ± 4.0 years, respectively; p ¼ 0.004; Table 1).
In all three groups, less than one-half of the embryos analyzed
by PGDwere normal (41 ± 31%, 48± 38%, and 48± 31% in theMESA,
TESA, and EJAC groups, respectively; Table 2). These rates were not
statistically signiﬁcant. The rates for haploidy, polyploidy, and
aneuploidy were also similar among these three groups. However,
Table 2
Chromosome abnormalities in MESA-, TESE-, and EJAC-derived embryos.
Group MESA
n (%)
TESE
n (%)
EJAC
n (%)
Total embryos 58 54 460
Euploid 21 (36.2) 24 (44.4) 225 (48.9)
Haploid 1 (1.7) 1 (1.9) 6 (1.3)
Polyploid 1 (1.7) 3 (5.6) 27 (5.9)
Aneuploid 7 (12.1) 6 (11.1) 80 (17.4)
Complex abnormality 28 (48.3)* 20 (37.0) 122 (26.5)*
EJAC ¼ ejaculation; MESA ¼ microsurgical epididymal sperm aspiration;
TESE ¼ testicular sperm extraction.
*p < 0.001.
Table 4
The number of abnormal copies in each studied chromosome.
Study group MESA TESE EJAC
Number of embryos 58 54 460
Chromosome no.
8 4/7 (57) 0 27/78 (35)
9 0 0 27/78 (35)
13 16/50 (32) 15/54 (25) 139/444 (30)
14 5/7 (71) 0 1/8 (13)
15 4/7 (57) 10/16 (63) 32/78 (41)
16 5/7 (71) 9/18 (50) 34/78 (44)
17 4/7 (57) 7/16 (44) 0
18 21/50 (42) 17/54 (31) 120/444 (27)
20 3/7 (43) 0 0
21 20/50 (40) 21/54 (39) 139/444 (31)
22 2/7 (29) 10/18 (56) 12/43 (30)
X and Y 19/50 (38) 17/54 (31) 131/444 (30)
EJAC ¼ ejaculation; MESA ¼ microsurgical epididymal sperm aspiration;
TESE ¼ testicular sperm extraction.
The data are presented as the number of embryos/total number of embryos
(percent).
The KruskaleWallis test was used to compare heterogeneous percentages among
the three studied groups. There was no statistical signiﬁcance noted in all investi-
gated chromosomes.
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group in comparison with the EJAC group (48.3% vs. 26.5%,
p < 0.001). The rates of complex abnormalities were not statistically
different between the MESA and TESE groups (Table 2).
Table 3 depicts the impact of the number of FISH probes that
were studied on the PGD results. When only ﬁve probes (chro-
mosomes 13, 18, 21, X, and Y) were used for PGD, the rates of
normal chromosomes were higher (42%, 67%, and 52% in the MESA,
TESE, and EJAC groups, respectively), compared with the rates
when using nine probes (data not shown). When using only ﬁve
probes, the rate of euploidy embryos from TESEwas higher than the
rate in embryos fromMESA (66.7% vs. 41.9%, respectively; p¼ 0.02).
The haploid, polyploid, and aneuploid patterns remained similar,
even when more than ﬁve probes were used. However, when ﬁve
probes were used, the difference in rates of complex abnormalities
was less signiﬁcant among these three groups (p¼ 0.06), compared
with when more than ﬁve probes were used (Tables 2 and 3).
Table 4 demonstrates that the rate of aneuploidy in each studied
chromosome was not different among these three groups. The rate
of abnormality in sex chromosomes did not differ from the rate of
autosomal chromosomes. There was no difference in the rates of
abnormality between the X and the Y chromosomes (data not
shown). The overall pattern of chromosomal aneuploidy was
similar among all three studied groups.Discussion
This study demonstrates that despite the fact that the MESA and
TESE procedures are performed in patients with the most severe
forms of male factor infertility, the rates of fertilization, embryo
cleavage, pregnancy, and euploidy are the same as those achieved
using ICSI cycles that use ejaculated sperm. In addition, the rate of
aneuploidy in embryos derived from MESA and TESE procedures is
not any higher than the rate in EJAC-derived embryos. However, the
rate of complex chromosomal abnormality is signiﬁcantly higher in
the MESA group.Table 3
Chromosome abnormalities in MESA-, TESE-, and EJAC-derived embryos using only
ﬁve probes (chromosomes 13, 18, 21, X, and Y).
Group MESA
n (%)
TESE
n (%)
EJAC
n (%)
Euploid 18 (41.9)* 24 (66.7)* 186 (52.1)
Haploid 1 (12.3) 1 (2.8) 5 (1.4)
Polyploid 1 (2.3) 2 (5.6) 19 (5.3)
Aneuploid 7 (16.3) 2 (5.6) 62 (17.4)
Complex abnormality 16 (37.2)** 7 (19.4) 86 (24.0)**
Total embryos 43 36 358
EJAC ¼ ejaculation; MESA ¼ microsurgical epididymal sperm aspiration;
TESE ¼ testicular sperm extraction.
*p ¼ 0.02; **p ¼ 0.06.There was a higher incidence of complex chromosomal abnor-
mality in MESA-derived embryos than in TESE and EJAC embryos.
This occurred with statistical signiﬁcance (Table 2) and without
statistical signiﬁcance (Table 3). Representative of the most chaotic
situation during chromosome meiosis, complex chromosomal ab-
normality appears to occur more often in MESA-derived embryos.
The exact cause of this phenomenon is unclear, although it may
partly result from the process of sperm maturation, which involves
testicular sperm acquiring fertilization potential during its passage
through the epididymis. Sperm chromatin is normally a highly
organized, compact structure that consists of DNA and heteroge-
neous nucleoproteins. For a spermatozoon to be fertile, it must be
able to undergo decondensation at the appropriate time in the
fertilization process; however, previous studies show that the
prolonged presence of the sperm in the epididymis may increase
the formation of disulﬁde bonds in human sperm protamines
[6,19]. There was a signiﬁcant increase in the decondensation time
for these overmature sperm, which increased their resistance to
nuclear decondensation in the in vitro-stored sperm and reﬂected
an increase in cross-linking within the sperm histones via the for-
mation of the disulﬁde bonds [6]. This phenomenon may induce a
higher risk of abnormal segregation processes in MESA embryos.
The effect of female age in severe male infertility on chromo-
somal abnormality is also a factor of great importance. Studies show
that a maternal age of greater than 40 years is more relevant to
increasing chromosomal abnormalities in embryos, compared with
a maternal age of less than 40 years [20,21]. In this study, the mean
female agewas higher in the EJAC group than in theMESA and TESE
groups, 38.5, 33.8, and 36.5 years, respectively. Therefore, the
negative impact ofmaternal age on the EJAC group in this studymay
not be signiﬁcant. The rates of normal chromosomes and pregnancy
rates in the EJAC group were not statistically different from these
rates in the MESA and TESE groups.
In the present study, the rates of normal chromosomes are, as
expected, higher if only ﬁve-chromosome probes are used in all
three groups (Tables 2 and 3). When more FISH probes are used for
analyses, a higher rate of chromosomal abnormality is detected.
The rate of complex abnormality was higher, whereas the rates of
haploidy, polyploidy, and aneuploidy remained the same. Complex
chromosomal abnormalities represent the most chaotic or
complicated situation in embryos that are derived in severe male
infertility, particularly in the MESA and TESE groups. However, the
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between the three groups. This interesting phenomenon may
indicate that the sperm from the MESA and TESE groups have
potentially more damage control in chromosome segregation. The
detailed mechanism therefore requires further elucidation.
To date, an increasing number of advanced molecular genetic
diagnostic technologies are available for PGD or for screening. For
instance, array comparative genomic hybridization (CGH) with
whole genome ampliﬁcation can detect translocations and 23 pairs
of chromosomes [22,23]. In the future, this technique may replace
traditional FISH in preimplantation screening [24,25]. Furthermore,
using blastocyst biopsy in the PGD proceduremay be able to reduce
misdiagnosis resulting frommosaicism because more than one cell
can be examined [26]. This is particularly important in the PGD for
embryos from TESE because of their high mosaic rates [12]. How-
ever, the blastocyst formation rate of the embryos derived from
TESE may not be satisfactory for blastocyst biopsy using array CGH.
In addition, the prevalence of nonobstructive azoospermia is low.
Therefore, until the case number is sufﬁcient for whole genome
array CGH, the information provided by the present study is still
useful for counseling patients at the time of embryos transfer in the
ICSI procedure. In embryos with more than six blastomeres on Day
3, a biopsy of two blastomeres may nevertheless be an alternative
option for couples undergoing in vitro fertilizationePGD for a
chromosome rearrangement because the embryo development and
clinical outcomes were similar between the biopsy of the one
blastomere group and the two blastomere group [27].
In conclusion, MESA and TESE, followed by ICSI and PGD, appear
to be acceptable approaches for treating men with severe sper-
matogenesis impairment, and exhibit clinical and laboratory results
that are comparable to using ejaculated sperm. However, more FISH
probes are necessary to assess the true incidence of chromosomal
abnormalities, particularly in more severe forms of male infertility,
when using sperm from MESA and TESE procedures.
Maternal age has a crucial impact on the rate of chromosomal
abnormality in embryos, although the patterns of the abnormality
do not signiﬁcantly change. The results of this study, which
compared chromosomal abnormalities in embryos that were
derived from TESE, MESA, and EJAC sperm, are important for clar-
ifying the impact of azoospermic male infertility on conception.
Conﬂicts of interest
The authors have no conﬂicts of interest to declare.
References
[1] Palermo G, Joris H, Devroey P, Van Steirteghem A. Pregnancies after intra-
cytoplasmic injection of single spermatozoon into an oocyte. Lancet
1992;340:17e8.
[2] Temple-Smith P, Southwick G, Yates C, Trounson A, de Kretser D. Human
pregnancy by in vitro fertilization (IVF) using sperm aspirated from the
epididymis. J In Vitro Fert Embryo Transf 1985;2:119e22.
[3] Silber S, Balmaceda J, Borrero C, Ord T, Asch R. Pregnancy with sperm aspi-
ration from the proximal head of the epididymis: a new treatment for
congenital absence of the vas deferens. Fertil Steril 1988;50:525e8.
[4] Silber S, Nagy Z, Liu J, Tournaye H, Lissens W, Ferec C, et al. The use of
epididymal and testicular spermatozoa for intracytoplasmic sperm injection:
the genetic implications for male infertility. Hum Reprod 1995;10:2031e43.[5] Silber S, Nagy Z, Devroey P, Camus M, Van Steirteghem A. The effect of female
age and ovarian reserve on pregnancy rate in male infertility: treatment of
azoospermia with sperm retrieval and intracytoplasmic sperm injection. Hum
Reprod 1997;12:2693e700.
[6] Beil RE, Graves CN. Nuclear decondensation of mammalian spermatozoa:
changes during maturation and in vitro storage. J Exp Zool 1977;202:
235e40.
[7] Palermo G, Schlegel P, Hariprashad J, Ergun B, Mielnik A, Zaninovic N, et al.
Fertilization and pregnancy outcome with intracytoplasmic sperm injection
for azoospermic men. Hum Reprod 1999;14:741e8.
[8] Moore H, Akhondi M. In vitro maturation of mammalian spermatozoa. Rev
Reprod 1996;1:54e60.
[9] Pellestor F, Girardet A, Andreo B. Effect of long abstinence periods on human
sperm quality. Int J Fertil Menopausal Stud 1994;39:278e82.
[10] Steele E, McClure N, Maxwell R, Lewis S. A comparison of DNA damage in
testicular and proximal epididymal spermatozoa in obstructive azoospermia.
Mol Hum Reprod 1999;5:831e5.
[11] Dozortsev D, Neme R, Diamond M, Abdelmassih S, Abdelmassih V, Oliveira F,
et al. Embryos generated using testicular spermatozoa have higher develop-
mental potential than those obtained using epididymal spermatozoa in men
with obstructive azoospermia. Fertil Steril 2006;86:606e11.
[12] Silber S, Escudero T, Lenahan K, Abdelhadi I, Kilani Z, Munne S. Chromosomal
abnormalities in embryos derived from testicular sperm extraction. Fertil
Steril 2003;79:30e8.
[13] Bonduelle M, Camus M, De Vos A, Staessen C, Tournaye H, Van Assche E, et al.
Seven years of intracytoplasmic sperm injection and follow-up of 1987 sub-
sequent children. Hum Reprod 1999;14:243e64.
[14] Aboulghar H, Aboulghar M, Mansour R, Serour G, Amin Y, Al-Inany H.
A prospective controlled study of karyotyping for 430 consecutive babies
conceived through intracytoplasmic sperm injection. Fertil Steril 2001;76:
249e53.
[15] Ludwig M, Geipel A, Berg C, Gembruch U, Schwinger E, Diedrich K. Is intra-
cytoplasmic sperm injection itself an indication to perform preimplantation
genetic diagnosis (PGD)? About PGD, invasive prenatal diagnosis and genetic
sonography. Fetal Diagn Ther 2001;16:68e82.
[16] Huang W, Lamb D, Kim E, de Lara J, Lin W, Lipshultz L, et al. Germ-cell
nondisjunction in testes biopsies of men with idiopathic infertility. Am J Hum
Genet 1999;64:1638e45.
[17] Gianaroli L, Magli M, Cavallini G, Crippa A, Nadalini M, Bernardini L, et al.
Frequency of aneuploidy in sperm from patients with extremely severe male
factor infertility. Hum Reprod 2005;20:2140e52.
[18] Pang M, Kim Y, Lee S, Kim C. The high incidence of meiotic errors increases
with decreased sperm count in severe male factor infertilities. Hum Reprod
2005;20:1688e94.
[19] Saowaros W, Panyim S. The formation of disulﬁde bonds in human prot-
amines during sperm maturation. Experientia 1979;35:191e2.
[20] Munne S, Alikani M, Tomkin G, Grifo J, Cohen J. Embryo morphology, devel-
opmental rates, and maternal age are correlated with chromosome abnor-
malities. Fertil Steril 1995;64:382e91.
[21] Marquez C, Sandalinas M, Bahce M, Alikani M, Munne S. Chromosome ab-
normalities in 1255 cleavage-stage human embryos. Reprod Biomed Online
2000;1:17e26.
[22] Chang LJ, Chen SU, Tsai YY, Hung CC, Fang MY, Su YN, et al. An update of
preimplantation genetic diagnosis in gene diseases, chromosomal trans-
location, and aneuploidy screening. Clin Exp Reprod Med 2011;38:
126e34.
[23] Munne S. Preimplantation genetic diagnosis for aneuploidy and translocations
using array comparative genomic hybridization. Curr Genomics 2012;13:
463e70.
[24] Rubio C, Rodrigo L, Mir P, Mateu E, Peinado V, Milan M, et al. Use of array
comparative genomic hybridization (array-CGH) for embryo assessment:
clinical results. Fertil Steril 2013;99:1044e8.
[25] Hens K, Dondorp W, Handyside AH, Harper J, Newson AJ, Pennings G, et al.
Dynamics and ethics of comprehensive preimplantation genetic testing: a
review of the challenges. Hum Reprod Update 2013;19:366e75.
[26] Chen YL, Hung CC, Lin SY, Fang MY, Tsai YY, Chang LJ, et al. Successful
application of the strategy of blastocyst biopsy, vitriﬁcation, whole genome
ampliﬁcation, and thawed embryo transfer for preimplantation genetic
diagnosis of neuroﬁbromatosis type 1. Taiwan J Obstet Gynecol 2011;50:
74e8.
[27] Brodie D, Beyer CE, Osborne E, Kralevski V, Rasi S, Osianlis T. Preimplantation
genetic diagnosis for chromosome rearrangementsdone blastomere biopsy
versus two blastomere biopsy. J Assist Reprod Genet 2012;29:821e7.
